NCT06903663View on ClinicalTrials.gov

The Epidemiology of Patients Treated With ATZ+BEV in Real Life Setting

Not yet recruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

April 30, 2025

Primary Completion Date

July 31, 2025

Study Completion Date

December 31, 2025

Conditions
Hepatocellular Carcinoma (HCC)
Trial Locations (4)

300239

Oncohelp, Timișoara

400162

"Regional Institute of Gastroenterology and Hepatology Prof. Dr. Octavian Fodor", Cluj-Napoca

700483

Regional Institute of Oncology, Iași

022328

Fundeni Clinical Institute, Bucharest

Sponsors

Collaborators (1)

MDX Research
All Listed Sponsors
collaborator

MDX Research

NETWORK

lead

Institutul Regional de Gastroenterologie & Hepatologie Prof. dr. Octavian Fodor

OTHER

NCT06903663 - The Epidemiology of Patients Treated With ATZ+BEV in Real Life Setting | Biotech Hunter | Biotech Hunter